Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
80.73
+2.47 (3.16%)
Apr 1, 2025, 2:45 PM CST
SHE:300573 Revenue
Shenyang Xingqi Pharmaceutical had revenue of 547.49M CNY in the quarter ending September 30, 2024, with 30.54% growth. This brings the company's revenue in the last twelve months to 1.80B, up 33.44% year-over-year. In the year 2023, Shenyang Xingqi Pharmaceutical had annual revenue of 1.47B with 17.42% growth.
Revenue (ttm)
1.80B
Revenue Growth
+33.44%
P/S Ratio
7.82
Revenue / Employee
903.26K
Employees
1,995
Market Cap
14.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.47B | 217.71M | 17.42% |
Jan 1, 2023 | 1.25B | 221.94M | 21.59% |
Jan 1, 2022 | 1.03B | 339.23M | 49.26% |
Dec 31, 2020 | 688.68M | 146.25M | 26.96% |
Dec 31, 2019 | 542.43M | 111.23M | 25.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Sichuan Biokin Pharmaceutical | 5.82B |